Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells-Reference-Cited by-同舟云学术

Transcriptional mechanism of vascular endothelial growth factor-induced expression of protein kinase CβII in chronic lymphocytic leukaemia cells

Published:2017-02-24 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Al-Sanabra Ola,Duckworth Andrew D.,Glenn Mark A.,Brown Benjamin R. B.,Angelillo Piera,Lee Kelvin,Herbert John,Falciani Francesco,Kalakonda Nagesh,Slupsky Joseph R.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep43228.pdf

Reference54 articles.

1. Watson, L., Wyld, P. & Catovsky, D. Disease burden of chronic lymphocytic leukaemia within the European Union. Eur J Haematol 81, 253–258 (2008).

2. Dighiero, G. & Hamblin, T. J. Chronic lymphocytic leukaemia. Lancet 371, 1017–1029 (2008).

3. Abrams, S. T. et al. B-cell receptor signaling in chronic lymphocytic leukemia cells is regulated by overexpressed active protein kinase CβII. Blood 109, 1193–1201 (2007).

4. Newton, A. C. Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 298, E395–402 (2010).

5. Saijo, K. et al. Protein kinase Cβ controls nuclear factor κactivation in B cells through selective regulation of the IκB kinaseas. J. Exp. Med. 195, 1647–1652 (2002).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seven non-differentially expressed ‘dark biomarkers’ show transcriptional dysregulation in chronic lymphocytic leukemia;Personalized Medicine;2023-03

2. PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling;Cancers;2022-12-06

3. Identifying a novel ferroptosis-related prognostic score for predicting prognosis in chronic lymphocytic leukemia;Frontiers in Immunology;2022-10-06

4. PKCβ facilitates leukemogenesis in chronic lymphocytic leukaemia by promoting constitutive BCR-mediated signaling;2022-09-04

5. ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model;Blood;2019-08-01